Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity.

Leventhal DS, Sokolovska A, Li N, Plescia C, Kolodziej SA, Gallant CW, Christmas R, Gao JR, James MJ, Abin-Fuentes A, Momin M, Bergeron C, Fisher A, Miller PF, West KA, Lora JM. · 2020

Read Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity. by Leventhal DS, Sokolovska A, Li N, Plescia C, Kolodziej SA, Gallant CW, Christmas R, Gao JR, James MJ, Abin-Fuentes A, Momin M, Bergeron C, Fisher A, Miller PF, West KA, Lora JM. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7264239.txt.

Description

Leventhal and co-authors engineer a harmless gut bacterium into a living cancer medicine. Their study appeared in Nature Communications. The strain, called SYNB1891, is built from non-pathogenic E. coli Nissle. It is designed to reach tumors and switch on the STING pathway, an alarm system inside immune cells.

Once swallowed up by antigen-presenting cells in the tumor, the bacteria trigger STING and other innate immune pathways together. In mouse tumor models, treatment produced strong anti-tumor immunity and lasting immunological memory. Human immune cells in the lab also responded robustly. Built-in containment features keep the strain from surviving where it should not. The authors present the work as a roadmap for designing living medicines that meet manufacturing and safety rules from the start.

Catalog record

CREATORLeventhal DS, Sokolovska A, Li N, Plescia C, Kolodziej SA, Gallant CW, Christmas R, Gao JR, James MJ, Abin-Fuentes A, Momin M, Bergeron C, Fisher A, Miller PF, West KA, Lora JM.
YEAR2020
COLLECTIONPAPERS
FORMATTXT
FILE SIZE91 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7264239

Browse the full library · About the Tower of Babel